Beyond bile acids synthesis: metabolomics profiling highlights extensive metabolic dysregulation and treatment response in CTX. [PDF]
Del Monte MA, Hanson J, Bonnen PE.
europepmc +1 more source
Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry. [PDF]
Surcinelli A +35 more
europepmc +1 more source
The sphingolipid metabolite sphingosine protects against hypertension by targeting metabolic-inflammatory crosstalk via the NLRP3 inflammasome. [PDF]
Li W +7 more
europepmc +1 more source
Mechanisms and potential therapeutic targets of SphK1 and SphK2 in hepatocellular carcinoma. [PDF]
Xu X +9 more
europepmc +1 more source
Mast cell corticotropin-releasing factor receptor 1 contributes to pancreatic cancer pain via mitogen-activated protein kinase/sphingosine kinases type 1 signaling. [PDF]
Zhang Y, Wei K, Tao K, Ma M, Lu Z.
europepmc +1 more source
Sphingolipid Metabolism in the Pathogenesis of Hashimoto's Thyroiditis. [PDF]
Huang J +4 more
europepmc +1 more source
Metformin Induces Changes in Sphingosine-1-Phosphate-Related Signaling in Diabetic Mice Brain. [PDF]
Wencel PL +4 more
europepmc +1 more source
Sphingosine‑1‑phosphate receptor 1 enhances olfactory receptor 51E1‑mediated inhibition of proliferation via Src/JNK signaling in prostate cancer cells. [PDF]
Kim K +5 more
europepmc +1 more source
Sphingolipids in Gaucher disease: a systematic review. [PDF]
Lake A, Fuller M.
europepmc +1 more source

